In a distinct set of HNSCC cells, Brand et al. [18] also showed that treatment with BGB324 led to decreased proliferation in AXL positive, but not in AXL negative cell lines, with comparable IC50 values to HN and SCC-25. The gene discussed is AXL; the disease is head and neck squamous cell carcinoma.